China’s Fosun group has agreed to pare its proposed holding in the Indian injectables firm Gland Pharma Ltd. as part of certain revised terms pertaining to the mega deal, currently in limbo in India.
The deal has already been cleared by India’s Foreign Investment Promotion Board (FIPB) [although the FIPB itself has since been...